BioSpace News Archive

DiviTum(R) TKa Results to be Presented at ASCO

Biovica, active in cancer diagnostics, announces that a poster with DiviTum® TKa results from the SWOG study S0226 will be presented at the the world’s largest cancer conference, the annual ASCO meeting, on Sunday, June 4.

June 1, 2023
·
2 min read
Satellos Bioscience Announces Grant of Stock Options

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, today announced that its board of directors

June 1, 2023
·
3 min read
Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma

Zenith Epigenetics Ltd. (“Zenith” or the “Company”) reports clinical activity and the advancement in development of its BET inhibitor (BETi) ZEN-3694 in patients with NUT carcinoma (NC). NC is a highly aggressive type of squamous cell cancer with very poor prognosis that often forms in the head, neck, or lungs.

June 1, 2023
·
6 min read
Business

Cognoa Announces Leadership Expansion with Strategic Hires

Cognoa announced the expansion of its leadership team supporting the commercialization of Canvas Dx, the first and only FDA authorized diagnostic that gives diverse providers the ability to diagnose or rule out autism in children ages 1.5 to 6 years at risk of developmental delay.

June 1, 2023
·
3 min read
Pharm Country

New Real-World Evidence from Personalized Trials Calls for Rethinking the Standard of Care for Non-Responders to Autoimmune Therapies

Today Mymee Inc announced new peer-reviewed and payer-audited research that sheds light on the enormous challenges facing autoimmune patients with joint flares, >30 moderate to high frequency symptoms, and inadequate response to pharmacological treatments.

June 1, 2023
·
4 min read
BioCapital

Study Confirms DISCERN™ Alzheimer’s Disease Diagnostic Projected to Save Nearly $5 Million Over Three Years for Medicare Advantage Plans, Avoids Inappropriate Prescribing of New, Expensive Medications

SYNAPS Dx is pleased to announce the publication of “The Budget Impact of the DISCERN™ Diagnostic Test for Alzheimer’s Disease in the United States” in Journal of Preventative Medicine.

June 1, 2023
·
4 min read
BioMidwest

Cantex Pharmaceuticals Obtains Exclusive Worldwide Rights to Intellectual Property From Georgetown University for Azeliragon as a Potential Treatment of Cancer-Related Cognitive Decline

Cantex Pharmaceuticals, Inc. announced that it has obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer-treatment related cognitive decline.

June 1, 2023
·
4 min read
Human Liver Models Market Size ($508.26Mn by 2028) Lead by Liver-on-a-Chip Type (11.7% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com

The new research study on the Human Liver Models Market Size and Forecast to 2028 by Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others)

June 1, 2023
·
5 min read
Pharmaceutical Isolator Market (Type, Pressure, Configuration) Size to Outstrip $10,560.30Mn by 2028 Growth Projections at 8.5% CAGR During 2021 to 2028 | The Insight Partners

According to our new research study on “Pharmaceutical Isolator Market to 2028 – Global Analysis and Forecast – by Type, Pressure, Configuration, Application, and End User,”

June 1, 2023
·
6 min read
Business

DELFI Diagnostics Hires David Morgenstern, PhD, as Vice President of Clinical Development

DELFI Diagnostics has hired Dave Morgenstern, PhD, as Vice President of Clinical Development.

June 1, 2023
·
1 min read